معرفی
Nazli Keskin, Ph.D., is an Assistant Professor at the Faculty of Engineering and Natural Sciences, Acibadem Mehmet Ali Aydinlar University, Turkey. She holds a Doctorate in Biological Sciences and Bioengineering from Sabanci University (2014) and a Master's in the same field from Sabanci University (2010). Her academic career spans institutions like Istanbul Okan University (2015-2018) and Acibadem University (2018-present), where she also serves as Deputy Head of Department and Program Coordinator.
- Doctorate: Sabanci University, 2014
- Master's: Sabanci University, 2010
- Bachelor's: Marmara University, 2008
Dr. Keskin's research focuses on Molecular Biology of Cancer, DNA Damage Response, and Transcription Factor Regulation, particularly the interplay between the p53 tumor suppressor and PATZ1 in cancer progression. Her work extends to CRISPR/Cas9 genome engineering in glioblastoma and colon carcinoma models.
Her recent articles highlight mechanisms of DNA damage-induced resistance, mitochondrial targeting in cancer, and CRISPR-based functional studies. These publications reflect her expertise in genomic stability and oncogenic pathways.
Scientific Awards:
- Oral Presentation Award, Molecular Cancer Research Association (MOKAD), 2023
- Outstanding Achievement in Teaching, Acibadem University, 2022
- Poster Award (1st place), 22nd National Immunology Congress, 2013
- Poster Award (1st place), EMBO Meeting, 2012
- Sabancı University Teaching Assistant Incentive Award, 2010
Dr. Keskin has advised graduate students such as B.Kavaklıoğlu on CRISPR/Cas9 applications in glioblastoma. She has contributed to TUBITAK-funded projects on p53 mutant effects in glioblastoma and 2-indolinone derivatives as anti-interleukin agents. Her leadership roles include Assistant Director of the Graduate School and Deputy Head of Department.
